These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28604647)

  • 21. Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms.
    Zhang H; Zhao Z; Wang H
    Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28287431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicinal benefits of marine invertebrates: sources for discovering natural drug candidates.
    De Zoysa M
    Adv Food Nutr Res; 2012; 65():153-69. PubMed ID: 22361185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine peptides and their anti-infective activities.
    Kang HK; Seo CH; Park Y
    Mar Drugs; 2015 Jan; 13(1):618-54. PubMed ID: 25603351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying carbohydrate self-recognition in marine sponges using synthetic aggregation factor epitopes.
    Kamerling JP; de Souza AC
    Adv Exp Med Biol; 2011; 705():493-510. PubMed ID: 21618126
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioactive secondary metabolites from marine microbes for drug discovery.
    Nikapitiya C
    Adv Food Nutr Res; 2012; 65():363-87. PubMed ID: 22361200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New marine natural products from sponges (Porifera) of the order Dictyoceratida (2001 to 2012); a promising source for drug discovery, exploration and future prospects.
    Mehbub MF; Perkins MV; Zhang W; Franco CMM
    Biotechnol Adv; 2016; 34(5):473-491. PubMed ID: 26802363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Epibionts of Bacteria of the Genus Pseudoalteromonas and Cellular Proteasomes in the Adaptive Plasticity of Marine Cold-Water Sponges.
    Kravchuk OI; Lavrov AI; Finoshin AD; Gornostaev NG; Georgiev AA; Abaturova SB; Mikhailov VS; Lyupina YV
    Dokl Biochem Biophys; 2018 Mar; 479(1):77-79. PubMed ID: 29779101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural products potential of Dictyoceratida sponges-associated micro-organisms.
    Abdelaleem ER; Samy MN; Abdelmohsen UR; Desoukey SY
    Lett Appl Microbiol; 2022 Jan; 74(1):8-16. PubMed ID: 34496057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of sponges and microalgae for marine biotechnology.
    Wijffels RH
    Trends Biotechnol; 2008 Jan; 26(1):26-31. PubMed ID: 18037175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and Bioactive Studies of Halogenated Constituents from Sponges.
    Li C; Shi D
    Curr Med Chem; 2020; 27(14):2335-2360. PubMed ID: 30417770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary metabolites from marine organisms.
    Rinehart KL
    Ciba Found Symp; 1992; 171():236-49; discussion 249-54. PubMed ID: 1302180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marine bacterial sources of bioactive compounds.
    Jaiganesh R; Sampath Kumar NS
    Adv Food Nutr Res; 2012; 65():389-408. PubMed ID: 22361201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing calcareous sponges and their associated bacteria for the discovery of new bioactive natural products.
    Roué M; Quévrain E; Domart-Coulon I; Bourguet-Kondracki ML
    Nat Prod Rep; 2012 Jul; 29(7):739-51. PubMed ID: 22660834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer agents from marine sponges.
    Ye J; Zhou F; Al-Kareef AM; Wang H
    J Asian Nat Prod Res; 2015; 17(1):64-88. PubMed ID: 25402340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-Apoptotic Activity of the Marine Sponge
    Carpi S; Scoditti E; Polini B; Brogi S; Calderone V; Proksch P; Ebada SS; Nieri P
    Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trends in phospholipid class composition of marine sponges.
    Genin E; Wielgosz-Collin G; Njinkoué JM; Velosaotsy NE; Kornprobst JM; Gouygou JP; Vacelet J; Barnathan G
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Aug; 150(4):427-31. PubMed ID: 18541449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marine Organisms with Anti-Diabetes Properties.
    Lauritano C; Ianora A
    Mar Drugs; 2016 Dec; 14(12):. PubMed ID: 27916864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs from the seas - current status and microbiological implications.
    Proksch P; Edrada RA; Ebel R
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):125-34. PubMed ID: 12111137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyacetylenes of marine origin: chemistry and bioactivity.
    Zhou ZF; Menna M; Cai YS; Guo YW
    Chem Rev; 2015 Feb; 115(3):1543-96. PubMed ID: 25525670
    [No Abstract]   [Full Text] [Related]  

  • 40. Sustainable production of bioactive compounds by sponges--cell culture and gene cluster approach: a review.
    Müller WE; Grebenjuk VA; Le Pennec G; Schröder H; Brümmer F; Hentschel U; Müller IM; Breter H
    Mar Biotechnol (NY); 2004; 6(2):105-17. PubMed ID: 15085406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.